Anti-Trastuzumab Antibody (AY1b) (recommended for PK/PD)
抗体来源(Source)
Anti-Trastuzumab Antibody (AY1b) is a Mouse monoclonal antibody recombinantly expressed from HEK293 cells.
克隆号(Clone)
AY1b
种属(Species)
Mouse
亚型(Isotype)
Mouse IgG1/kappa
抗体类型(Antibody Type)
Recombinant Monoclonal
种属反应性(Reactivity)
Human
免疫原(Immunogen)
Trastuzumab.
特异性(Specificity)
Recognizes Trastuzumab specifically, no cross reactivity with other humanized antibodies.
应用(Application)
纯度(Purity)
>95% as determined by SDS-PAGE.
纯化(Purification)
Protein A purified/ Protein G purified
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 12 months under sterile conditions after reconstitution.
背景(Background)
曲妥珠单抗是一种用于治疗癌症的单克隆抗体。具体而言,其用于HER2受体阳性的乳腺癌症。曲妥珠单抗通过与HER2受体结合并减缓细胞复制来发挥作用。曲妥珠单抗是一种重组IgG1κ人源化单克隆抗体,在基于细胞的测定中(Kd=5 nM)以高亲和力选择性结合人表皮生长因子受体蛋白的细胞外结构域。
关键字: Trastuzumab;曲妥珠单抗;Trastuzumab抗体;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。